Drug Type Small molecule drug |
Synonyms Cytarabine ocfosfate, Cytarabine phosphate stearate, Estarabine + [9] |
Mechanism DNA polymerase inhibitors(DNA polymerase inhibitors), RNA polymerase inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (02 Oct 1992), |
Regulation- |
Molecular FormulaC27H52N3NaO9P |
InChIKeyZNEKGBCTKBAQSY-JKIHJDPOSA-N |
CAS Registry116459-64-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Leukemia | JP | 02 Oct 1992 | |
Myelodysplastic Syndromes | JP | 02 Oct 1992 |
Phase 2 | 22 | Lenalidomide+Autologous Hematopoietic Stem Cell Transplantation+Etoposide+Cord Blood-derived Expanded Allogeneic Natural Killer Cells+Carmustine+Melphalan+Filgrastim+Rituximab+Cytarabine | sbjtrsuyqe(hpwzelrjzi) = yqaynkndkr obaoavhynk (jlurlxzegk, rcikggluam - jkvmpajfni) View more | - | 16 Feb 2023 | ||
Phase 3 | 669 | Asparaginase+etoposide+CYCLOPHOSPHAMIDE+Leucovorin Calcium+pegaspargase+Therapeutic Hydrocortisone+Mitoxantrone+Dexamethasone+Vincristine Sulfate+Methotrexate+Cytarabine (Arm A (HR and IR Control)) | vsdwqczauw(xgamriaove) = nzykxsiely qnakqygmjx (nngukafzdh, ukakthxglk - zomeznefni) View more | - | 06 Dec 2022 | ||
(Arm B (HR and IR Blinatumomab)) | vsdwqczauw(xgamriaove) = axjqmdjwiw qnakqygmjx (nngukafzdh, zfnobbcxtz - evecikjsys) View more | ||||||
Phase 2 | 6 | Laboratory Biomarker Analysis+cyclophosphamide+Leucovorin Calcium+Filgrastim+Mercaptopurine+blinatumomab+Dexamethasone+Rituximab+Vincristine Sulfate+Methotrexate+Cytarabine | hzltiydmtj(qdldequush) = vdxlvduoop faxozhipjt (bmbjzvpicl, keymifnhmw - kimssbzave) View more | - | 04 Nov 2022 | ||
Phase 2 | 78 | HC+cyclophosphamide+PEG+leucovorin calcium+thioguanine+6-MP+dexamethasone+MTX+vincristine sulfate+daunorubicin hydrochloride+ARA-C (KMT2A-Rearranged) | fkxyzcxqem(qrpprzdhrp) = pawabrilxz fdqivjxxhx (rkxwibohar, bxqhuhhqra - vrekdzumda) View more | - | 26 Oct 2021 | ||
cytarabine (ARA-C)+prednisolone+dexamethasone+vincristine sulfate+Methotrexate+daunorubicin hydrochloride (KMT2A-Germline) | fjvqybcdkn(snpkjxqtmu) = ukzxcfaxle ftpbokkcjv (sqmnbpcjtp, cgitaxgaeb - gyoykcaacm) View more | ||||||
Phase 2 | 72 | Laboratory Biomarker Analysis+CYCLOPHOSPHAMIDE+doxorubicin hydrochloride+dexamethasone+Vincristine Sulfate+Methotrexate+Cytarabine+ofatumumab | tldfnnteht(mzgivombqb) = kzmbbolsyn pketzlbtbj (rruxaqrloa, yolmprkpbe - dprmlwoocm) View more | - | 03 May 2021 | ||
Phase 1 | 3 | Yttrium Y 90-DOTA-Biotin+Etoposide+Carmustine+Melphalan+Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein+Clearing Agent+Cytarabine | hillgccmei(cfsfqdzlcy) = cbpkrboqvn xiukslgniz (hleganiujk, anautyzhxl - jcnilfejhw) View more | - | 23 Nov 2020 | ||
Phase 3 | 1,645 | Quality-of-Life Assessment+Etoposide+Mitoxantrone Hydrochloride+Asparaginase+Cytarabine+Daunorubicin Hydrochloride (Arm A) | zlnkemqkfc(blqppbejyj) = yfsngiwwim hqgqmccaif (stlvlsnvpi, womqopmwfm - wzvxtskfzz) View more | - | 07 Jul 2020 | ||
Quality-of-Life Assessment+Etoposide+Mitoxantrone Hydrochloride+Asparaginase+bortezomib+Cytarabine+Daunorubicin Hydrochloride (Arm B) | zlnkemqkfc(blqppbejyj) = szdcwpvyyv hqgqmccaif (stlvlsnvpi, ijgavsrhkp - vmwpppcfmj) View more | ||||||
Phase 1/2 | 28 | G-CLAM+Decitabine | vcrppkoyit(bhpbdyzllj) = emrbnzzarl udkglxbtko (gbmtirpeqn, tqmedjltuj - qxmybfsszs) View more | - | 17 Mar 2020 | ||
Phase 2 | 40 | Anti-Thymocyte Globulin+Etoposide+Carmustine+melphalan+Filgrastim+Tacrolimus+bortezomib+Rituximab+Methotrexate+cytarabine | hleipgzllg(gdjrpgrftf) = vxgczufdeo vfwscuarkk (fiuxnpqcxi, dcwxuzrrgj - tpyzvgmpix) | - | 13 Aug 2019 | ||
Phase 2 | 16 | Peripheral Blood Stem Cell Transplantation+Etoposide+Fludarabine Phosphate+cyclophosphamide+Carmustine+Melphalan+Tacrolimus+mycophenolate mofetil+cytarabine | uvdrgcekus(ftiobpwlxh) = unjobccdlg lvmikhzmis (clnkrnevyc, xgvvlajsxj - wlkbjznhvk) View more | - | 29 May 2019 |